This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Osteoneurogen Inc., Binex Co., Ltd.. Active years: 2003-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2022
Title: Innovations of Ik Hwan Kim
Introduction
Ik Hwan Kim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory compositions and treatments for fibrosis.
Latest Patents
Ik Hwan Kim holds a total of 3 patents. His latest patents include an anti-inflammatory composition that inhibits inflammatory responses by targeting the interaction between CD14 and LPS. This composition effectively blocks the expression of key inflammatory factors such as TNFα and IL-1β. Additionally, he has developed substituted chromenes aimed at treating fibrosis and non-alcoholic steatohepatitis, showcasing his innovative approach to addressing complex health issues.
Career Highlights
Throughout his career, Ik Hwan Kim has worked with various companies, including Osteoneurogen Inc. and Binex Co., Ltd. His work in these organizations has allowed him to advance his research and contribute to the development of new therapeutic solutions.
Collaborations
Ik Hwan Kim has collaborated with notable colleagues, including Byung Soo Youn and Han Soo Kim. These partnerships have played a crucial role in enhancing his research and expanding the impact of his inventions.
Conclusion
Ik Hwan Kim's innovative work in the field of pharmaceuticals highlights his commitment to addressing significant health challenges through his inventions. His contributions continue to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile